Markets › India › NSE › SHUKRAPHAR

Shukra Pharmaceuticals Ltd.

NSE:SHUKRAPHARHealth Technology

₹68.62−0.38%At closeAt close · Mon 19 Oct · ≈ AED 2.65 · Market cap $307.17M

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	14.2%	15.7%	11.2%	30.8%	47.9%	54.0%	+6.1 pts
Operating margin	2.1%	6.0%	7.9%	23.3%	29.9%	45.1%	+15.3 pts
Net margin	1.6%	3.7%	7.5%	24.9%	29.4%	38.9%	+9.5 pts
EBITDA margin	14.9%	14.1%	11.0%	26.1%	39.1%	51.2%	+12.1 pts
Return on equity	1.2%	4.6%	17.4%	32.2%	15.2%	24.5%	+9.3 pts
Return on assets	0.5%	2.1%	5.9%	23.8%	11.0%	18.8%	+7.7 pts
Return on capital employed	0.8%	5.4%	14.2%	27.3%	14.0%	27.1%	+13.1 pts
Debt / equity	0.6×	0.2×	0.2×	0.1×	0.1×	0.1×	−15.9%
Debt / assets	27.4%	9.6%	6.8%	4.1%	4.8%	4.3%	−0.5 pts
Interest coverage	7.1×	4.3×	16.5×	61.1×	18.7×	26.5×	+42.0%
Current ratio	2.3×	1.3×	1.2×	4.0×	3.8×	3.6×	−4.1%
Quick ratio	2.0×	0.9×	1.1×	3.1×	3.0×	3.0×	−0.5%
Cash ratio	0.1×	0.0×	0.1×	0.7×	−0.3×	−0.6×	−94.7%
Asset turnover	0.3×	0.6×	0.8×	1.0×	0.4×	0.5×	+28.6%
Inventory turnover	4.5×	3.5×	6.5×	4.0×	1.2×	1.7×	+39.1%
Receivables turnover	0.9×	2.1×	1.4×	2.3×	0.9×	1.0×	+16.4%
Dividend payout	0.0%	0.0%	1.7%	0.4%	45.7%	2.0%	−43.7 pts